BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
BRCA1
,
Apoptosis
,
Allergy to pollen
,
Neuron
,
Alcohol
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cb 10
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Cockayne syndrome B ATPase and stress-response gene ATF3 following genotoxic stress
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
Triple Stack of a Viologen Derivative in a CB[10] Pair.
Cucurbit[10]uril-based supramolecular radicals: Powerful arms to kill facultative anaerobic bacteria…
Controlled oligomeric guest stacking by cucurbiturils in water.
Synthesis of Naphthalimide Derivatives and Their Luminescence upon Complexation with Cucurbit[n]uril…
Cucurbit[10]uril-Based [2]Rotaxane: Preparation and Supramolecular Assembly-Induced Fluorescence Enh…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Sol…
Study of the Glutaminase Inhibitor CB-839 in Leukemia
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
Safety Study of TPI-287 to Treat CBS and PSP
Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ